← Back to all trials
Recruiting
NCT06292715
A Single-Arm Clinical Trial of Percutaneous Splenic Ablation Combined With Splenic Artery Occlusion for Secondary Hypersplenism.
Conditions: Secondary Hypersplenism
Sex: All
Ages: 18 Years – 65 Years
Healthy volunteers: No
Phase: NA
Enrollment: 35
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Location: Tianjin Medical University Cancer Institute & Hospital Tianjin Tianjin Municipality
Summary
This study assesses the effectiveness of microwave ablation of the spleen in conjunction with splenic artery occlusion for treating secondary hypersplenism.
Eligibility Criteria
Inclusion Criteria:
* 1\. written informed consent signed prior to enrolment 2. age \> 18 years, both sexes 3.Patients with severe hypersplenism secondary to cirrhosis with clinical diagnosis, White blood cells \
Source: ClinicalTrials.gov (NCT06292715). StuddyBuddy aggregates publicly available trial information.
